Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations.
Saved in:
| Title: | Response to the ASHM 2023 statement on the use of doxy-PEP in Australia: considerations and recommendations. |
|---|---|
| Authors: | Bell SFE; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD., Sweeney EL; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD., Kong FYS; University of Melbourne, Melbourne, VIC., Whiley DM; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD.; Pathology Queensland, Brisbane, QLD., Bradshaw CS; Melbourne Sexual Health Centre, Monash University, Melbourne, VIC., Tickner JA; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD. |
| Source: | The Medical journal of Australia [Med J Aust] 2024 Apr 15; Vol. 220 (7), pp. 356-360. Date of Electronic Publication: 2024 Mar 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1326-5377 (Electronic) Linking ISSN: 0025729X NLM ISO Abbreviation: Med J Aust Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
